Systemic sepsis following hemorrhagic shock: Alleviation with oral interleukin-6

Military Medicine

Volumn 162, Issue 5, 1997, Pages 366-370

  Rollwagen, Florence M ^a   Li, Ying Yue Y ^b   Pacheco, Nancy D ^a   Baqar, Shahida ^a  

^a NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^b SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM CONTAMINATION; BATTLE INJURY; FEMALE; HEMORRHAGIC SHOCK; INFECTION PREVENTION; INTESTINE INFECTION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SEPSIS; SPLANCHNIC BLOOD FLOW;

EID: 1842334515     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/162.5.366     Document Type: Article

References (17)

1. Cue JI, Peyton JC, Malangoni MA: Does blood transfusion or hemorrhagic shock Induce immunosuppression? J Trauma 1992; 32: 613-7.
2. Esrig BC, Frazee L, Stephenson SF, Polk HC Jr, Fulton RL, Jones CE: The predisposition to infection following hemorrhagic shock. Surg Gynecol Obstet 1977; 144: 915-7.
3. Baker JW, Deitch EA, Li M, Berg RD, Specian RD: Hemorrhagic shock induces bacterial translocation from the gut. J Trauma 1988; 28: 896-906.
4. Deitch EA: Bacterial translocation of the gut flora. J Trauma 1990; 30: S184-9.
5. Bark T, Katouli M, Ljungqvist O, Mollby R, Svenberg T: Bacterial translocation after non-lethal hemorrhage in the rat. Circ Shock 1993; 41: 60-5.
6. Smith AM: Stretching the limits of naval self-sufficiency: medical implications of war at sea. Navy Medicine 1995; November-December: 13.
7. Baqar S, Pacheco ND, Rollwagen FM: Modulation of mucosal immunity against Compylobocter jejuni by orally administered cytokines. Antimicrob Agents Chemother 1993; 37: 2688-92.
8. Rollwagen FM, Li YY, Pacheco ND, Nielsen TB: Systemic bacteraemia following haemorrhagic shock in mice: alleviation with oral interleukin 6. Cytokine 1996; 8: 121-9.
9. SAS User's Guide: Statistics Version 5. Cary, NC, SAS Institute, 1985.
10. Helle M, Boeije L, Aarden LA: Functional discrimination between interleukin 6 and interleukin 1. Eur J Immunol 1988; 18: 1535-40.
11. Abraham E, Freitas AA: Hemorrhage produces abnormalities in lymphocyte function and lymphokine generation. J Immunol 1989; 142: 899-906.
12. Stephan RN, Ayala A, Harkema JM, Dean RE, Border JR Chaudry IH: Mechanism of immunosuppression following hemorrhage: defective antigen presentation by macrophages. J Surg Res 1989; 46: 553-6.
13. Shirota K, LeDuy L, Yuan SY, Jothy S: Interleukin-6 and its receptor are expressed in human intestinal epithelial cells. Virchows Arch B Cell Pathol Incl Mol Pathol 1990; 58: 303-8.
14. Ohkawa F, Ikeda U, Kawasaki K, Kusano E, Igarashi M, Shimada K: Inhibitory effect of interleukin-6 on vascular smooth muscle contraction. Am J Physiol 1994; 266: H898-902.
15. Robbins RA, Springall DR, Warren JB, Kwon OJ, Buttery LDK, Wilson AJ, Adcock IM, Riveros-Moreno V, Moncada S, Polak J, Barnes PJ: Inducible nitric oxide synthase is increased in murine lung epithelial cells by cytokine stimulation. Biochem Biophys Res Commun 1994; 198: 835-43.
16. Koren S, Fleischmann WR Jr: Orally administered interferons suppress bone marrow function. Proc Soc Exp Biol Med 1993; 204: 155-64.
17. Cummins JM, Tompkins MB, Olsen RG, Tompkins WA, Lewis MG: Oral use of human alpha interferon in cats. J Biol Response Modif 1988; 7: 513-23.